ClinicalTrials.Veeva

Menu

Physical Activity in Patients With Systemic Lupus Erythematosus

U

University of Oviedo

Status

Not yet enrolling

Conditions

Lupus Erythematosus, Systemic

Treatments

Other: Patients with systemic lupus erythematosus

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Background. Systemic lupus erythematosus is a chronic autoimmune disease. Among its main clinical manifestations are musculoskeletal symptoms such as myopathies, arthritis, arthralgias or osteonecrosis. Physical activity can improve the perception of quality of life and well-being of these patients.

Objective. To assess the degree of physical activity in patients with systemic lupus erythematosus, and to identify the main clinical, sociodemographic and anthropometric variables that influence it.

Method. Ambispective cohort study. Sixty-three patients with systemic lupus erythematosus will be recruited. The primary variable will be the degree of physical activity (International Physical Activity Questionnaire). Secondary and modifying variables will be: fatigue (Fatigue Assessment Scale), health-related quality of life (Short Form-36 Health Survey), sleep disorders (Pittsburgh Sleep Quality Index), depressive (Beck Depression Inventory -II) and anxiety symptoms (Hamilton Anxiety Rating Scale), age, and disease activity, duration and damage. Possible confounding variables will be sex, toxic habits (smoking), diagnosis of other pathologies and exposure to therapy. In the analysis, the degree of physical activity of patients with lupus erythematosus will be calculated and a multiple regression analysis will be performed to evaluate the predictive model that best fits the degree of activity of these patients.

Expectedresults. To identify the degree of physical activity of patients with systemic lupus erythematosus and to identify the predictive model of physical activity in these patients.

Enrollment

63 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with a diagnosis of systemic lupus erythematosus
  • Of legal age
  • Residents in Spain
  • Who sign the informed consent document.

Exclusion criteria

  • Patients dependent in the development of activities of daily living.
  • Unable to ambulate without the help of third parties.
  • Who have undergone surgery in the last 6 months.

Trial design

63 participants in 1 patient group

Patients with systemic lupus erythematosus
Description:
Patients with systemic lupus erythematosus who will participate through an interview format with closed questions where no data will be collected that would allow identification of the subjects.
Treatment:
Other: Patients with systemic lupus erythematosus

Trial contacts and locations

1

Loading...

Central trial contact

Rubén Cuesta-Barriuso, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems